Results of the scales of oral mucositis and xerostomia
Scales
R1
R2
R3
R4
R5
Oral mucositis assessment scale (OMAS)
5
4.5
3.5
3
1
WHO oral mucositis grading scale
4
3
2
2
1
LENT-SOMA
4
4
3
3
2
R1: the first session before starting the combined treatment; R2: 72 h after the first combined treatment session; R3: 72 h after the second combined session; R4: 72 h after the third combined session: R5: 72 h after the fourth combined session (the last session)
The authors declare that they have no conflicts of interest.
Ethical approval
This study conforms to the Declaration of Helsinki ethical principles for medical research and was approved by the ethics committee at Damascus University, number 3779.
Consent to participate
Informed consent to participate in the study was obtained from the participant.
Consent to publication
Informed consent to publication was obtained from participant.
Availability of data and materials
All datasets analyzed for this study are included in the manuscript.
Funding
The study was funded by Damascus University, and the number is DU2022-3796. The funder had no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.
Mosel DD, Bauer RL, Lynch DP, Hwang ST. Oral complications in the treatment of cancer patients.Oral Dis. 2011;17:550–9. [DOI] [PubMed]
Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition.Lancet Oncol. 2006;7:326–35. [DOI] [PubMed]
Maria OM, Eliopoulos N, Muanza T. Radiation-Induced Oral Mucositis.Front Oncol. 2017;7:89. [DOI] [PubMed] [PMC]
Brown TJ, Gupta A. Management of Cancer Therapy-Associated Oral Mucositis.JCO Oncol Pract. 2020;16:103–9. [DOI] [PubMed]
Lalla RV, Peterson DE. Oral mucositis.Dent Clin North Am. 2005;49:167–84. [DOI] [PubMed]
Naidu MUR, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy-induced and/or radiation therapy-induced oral mucositis—complicating the treatment of cancer.Neoplasia. 2004;6:423–31. [DOI] [PubMed] [PMC]
Sonis ST. The pathobiology of mucositis.Nat Rev Cancer. 2004;4:277–84. [DOI] [PubMed]
Mañáková S, Puttonen KA, Raasmaja A, Männistö PT. Ara-C induces apoptosis in monkey fibroblast cells.Toxicol In Vitro. 2003;17:367–73. [DOI] [PubMed]
Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, et al. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.Cancer Treat Rev. 2007;33:448–60. [DOI] [PubMed]
Al-Ansari S, Zecha JAEM, Barasch A, Lange Jd, Rozema FR, Raber-Durlacher JE. Oral Mucositis Induced By Anticancer Therapies.Curr Oral Health Rep. 2015;2:202–11. [DOI] [PubMed] [PMC]
Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Jr WHL, Mulagha MT, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy.Cancer. 1999;85:2103–13. [DOI] [PubMed]
Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer.Dent Clin North Am. 2008;52:61–77. [DOI] [PubMed] [PMC]
Wong S, Wilder-Smith P. Pilot study of laser effects on oral mucositis in patients receiving chemotherapy.Cancer J. 2002;8:247–54. [DOI] [PubMed]
Ferreira AS, Macedo C, Silva AM, Delerue-Matos C, Costa P, Rodrigues F. Natural Products for the Prevention and Treatment of Oral Mucositis-A Review.Int J Mol Sci. 2022;23:4385. [DOI] [PubMed] [PMC]
Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, et al. Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.Support Care Cancer. 2020;28:2449–56. [DOI] [PubMed]
Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Cancer. 2020;126:4423–31.Erratum in: Cancer. 2021;127:3700. [DOI] [PubMed] [PMC]
Lima AGd, Villar RC, Jr GdC, Antequera R, Gil E, Rosalmeida MC, et al. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.Int J Radiat Oncol Biol Phys. 2012;82:270–5. [DOI] [PubMed]
Oton-Leite AF, Silva GBL, Morais MO, Silva TA, Leles CR, Valadares MC, et al. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.Lasers Surg Med. 2015;47:296–305. [DOI] [PubMed]
Klausner G, Troussier I, Canova C, Bensadoun R. Clinical use of photobiomodulation as a supportive care during radiation therapy.Support Care Cancer. 2022;30:13–9. [DOI] [PubMed]
Franco R, Lupi E, Iacomino E, Galeotti A, Capogreco M, Santos JMM, et al. Low-Level Laser Therapy for the Treatment of Oral Mucositis Induced by Hematopoietic Stem Cell Transplantation: A Systematic Review with Meta-Analysis.Medicina (Kaunas). 2023;59:1413. [DOI] [PubMed] [PMC]
Kapourani A, Kontogiannopoulos KN, Barmpalexis P. A Review on the Role of Pilocarpine on the Management of Xerostomia and the Importance of the Topical Administration Systems Development.Pharmaceuticals (Basel). 2022;15:762. [DOI] [PubMed] [PMC]
Taweechaisupapong S, Pesee M, Aromdee C, Laopaiboon M, Khunkitti W. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer.Aust Dent J. 2006;51:333–7. [DOI] [PubMed]
Frydrych AM, Davies GR, Slack-Smith LM, Heywood J. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.Aust Dent J. 2002;47:249–53. [DOI] [PubMed]
Zecha JAEM, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, et al. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.Support Care Cancer. 2016;24:2793–805. [DOI] [PubMed] [PMC]
Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management.Bone Marrow Transplant. 2001;27 Suppl 2:S3–11. [DOI] [PubMed]
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.Cancer. 2004;100:1995–2025. [DOI] [PubMed]
Saadeh CE. Chemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.Pharmacotherapy. 2005;25:540–54. [DOI] [PubMed]
Oronsky B, Goyal S, Kim MM, Cabrales P, Lybeck M, Caroen S, et al. A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.Transl Oncol. 2018;11:771–8. [DOI] [PubMed] [PMC]
Bjordal JM, Bensadoun R, Tunèr J, Frigo L, Gjerde K, Lopes-Martins RA. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis.Support Care Cancer. 2011;19:1069–77. [DOI] [PubMed]
Simões A, Ganzerla E, Yamaguti PM, Eduardo CdP, Nicolau J. Effect of diode laser on enzymatic activity of parotid glands of diabetic rats.Lasers Med Sci. 2009;24:591–6. [DOI] [PubMed]
Libik TV, Gileva OS, Danilov KV, Grigorev SS, Pozdnyakova AA, editors. Management of cancer therapy-induced oral mucositis pain and xerostomia with extra-and intra oral laser irradiation. In: AIP Conference Proceedings. New York: AIP Publishing; 2017.
Louzeiro GC, Cherubini K, Figueiredo MAZd, Salum FG. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial.J Photochem Photobiol B. 2020;209:111933. [DOI] [PubMed]
Dantas JBL, Martins GB, Lima HR, Carrera M, Reis SRdA, Medrado ARAP. Evaluation of preventive laser photobiomodulation in patients with head and neck cancer undergoing radiochemotherapy: Laser in patients with head and neck cancer.Spec Care Dentist. 2020;40:364–73. [DOI] [PubMed]
Beech N, Robinson S, Porceddu S, Batstone M. Dental management of patients irradiated for head and neck cancer.Aust Dent J. 2014;59:20–8. [DOI] [PubMed]
Bodner L, Dayan D. Epithelium and connective tissue regeneration during palatal wound healing in desalivated rats—a comparative study.Comp Biochem Physiol A Physiol. 1995;111:415–9. [DOI] [PubMed]
Pronin AN, Wang Q, Slepak VZ. Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor.Mol Pharmacol. 2017;92:601–12. [DOI] [PubMed] [PMC]
Cifuentes M, Barrio-Díaz PD, Vera-Kellet C. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.Br J Dermatol. 2018;179:1056–61. [DOI] [PubMed]
Nyárády Z, Németh A, Bán A, Mukics A, Nyárády J, Ember I, et al. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.Anticancer Res. 2006;26:1557–62. [PubMed]
